Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from MedPlus Health Services Ltd. ( (IN:MEDPLUS) ).
MedPlus Health Services Limited has disclosed that its subsidiary, Optival Health Solutions Private Limited, has received a one-day suspension order of the drug license for a retail store located on KC Rani Road in Gadag, Karnataka, issued by the Assistant Director of the state Drugs Control Administration. The suspension, imposed under Rule 65 of the Drugs and Cosmetics Act, 1940 and corresponding rules, is expected to result in an estimated potential revenue loss of about Rs 0.23 lakh, suggesting only a minimal financial and operational impact on the company’s overall business and stakeholders.
More about MedPlus Health Services Ltd.
MedPlus Health Services Limited operates in the healthcare and retail pharmacy industry, providing pharmaceutical products and related health solutions through its stores across India. The company serves consumers with prescription medicines, over-the-counter drugs and other health-related products, and conducts part of its operations via its subsidiary Optival Health Solutions Private Limited.
Average Trading Volume: 21,257
Technical Sentiment Signal: Buy
Current Market Cap: 96.9B INR
See more insights into MEDPLUS stock on TipRanks’ Stock Analysis page.